Viridian Therapeutics, Inc.\DE SEC filings VRDN
Viridian Therapeutics, Inc.\DE has 817 filings in SEC EDGAR's recent list, going back to Nov 12, 2013. Its latest annual report, Form ARS, was filed on Apr 17, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B5 | Prospectus supplement | May 8, 2026 | — |
| 424B5 | Prospectus supplement | May 8, 2026 | — |
| FWP | Free writing prospectus | May 7, 2026 | — |
| FWP | Free writing prospectus | May 7, 2026 | — |
| 424B5 | Prospectus supplement | May 6, 2026 | — |
| 424B5 | Prospectus supplement | May 6, 2026 | — |
| FWP | Free writing prospectus | May 5, 2026 | — |
| S-8 | Employee stock plan registration | Feb 26, 2026 | — |
| 424B5 | Prospectus supplement | Oct 23, 2025 | — |
| 424B5 | Prospectus supplement | Oct 21, 2025 | — |
| S-3ASR | Automatic shelf registration | Sep 5, 2025 | — |
| S-8 | Employee stock plan registration | Aug 6, 2025 | — |
| 424B5 | Prospectus supplement | Mar 4, 2025 | — |
| S-8 | Employee stock plan registration | Mar 3, 2025 | — |
| 424B5 | Prospectus supplement | Sep 13, 2024 | — |
| 424B5 | Prospectus supplement | Sep 10, 2024 | — |
| S-8 | Employee stock plan registration | Aug 12, 2024 | — |
| S-8 | Employee stock plan registration | Feb 28, 2024 | — |
| 424B5 | Prospectus supplement | Jan 19, 2024 | — |
| 424B5 | Prospectus supplement | Jan 17, 2024 | — |
| S-3ASR | Automatic shelf registration | Nov 30, 2023 | — |
| S-8 | Employee stock plan registration | Aug 8, 2023 | — |
| S-3ASR | Automatic shelf registration | Jul 24, 2023 | — |
| S-8 | Employee stock plan registration | Mar 10, 2023 | — |
| S-3ASR | Automatic shelf registration | Sep 9, 2022 | — |
| 424B5 | Prospectus supplement | Aug 18, 2022 | — |
| 424B3 | Prospectus | Aug 17, 2022 | — |
| S-8 POS | Filing | Aug 16, 2022 | — |
| S-8 POS | Filing | Aug 16, 2022 | — |
| S-8 | Employee stock plan registration | Aug 16, 2022 | — |
| 424B5 | Prospectus supplement | Aug 15, 2022 | — |
| S-8 | Employee stock plan registration | Mar 11, 2022 | — |
| S-3 | Shelf registration | Nov 8, 2021 | — |
| 424B5 | Prospectus supplement | Sep 22, 2021 | — |
| 424B5 | Prospectus supplement | Sep 20, 2021 | — |
| 424B3 | Prospectus | Apr 23, 2021 | — |
| 424B5 | Prospectus supplement | Apr 23, 2021 | — |
| S-8 | Employee stock plan registration | Mar 26, 2021 | — |
| 424B5 | Prospectus supplement | Dec 23, 2020 | — |
| S-3 | Shelf registration | Dec 15, 2020 | — |
| 424B5 | Prospectus supplement | Dec 11, 2020 | — |
| S-8 | Employee stock plan registration | Nov 24, 2020 | — |
| S-3 | Shelf registration | Mar 26, 2020 | — |
| S-8 | Employee stock plan registration | Mar 13, 2020 | — |
| 424B5 | Prospectus supplement | Feb 7, 2020 | — |
| 424B5 | Prospectus supplement | Feb 6, 2020 | — |
| 424B5 | Prospectus supplement | Dec 12, 2019 | — |
| S-8 | Employee stock plan registration | Mar 14, 2019 | — |
| S-8 | Employee stock plan registration | Mar 15, 2018 | — |
| 424B5 | Prospectus supplement | Feb 9, 2018 | — |
| 424B5 | Prospectus supplement | Feb 5, 2018 | — |
| 424B5 | Prospectus supplement | Apr 25, 2017 | — |
| S-3 | Shelf registration | Mar 31, 2017 | — |
| S-8 | Employee stock plan registration | Feb 17, 2017 | — |
| 424B3 | Prospectus | Jan 9, 2017 | — |
| S-4/A | Filing | Jan 6, 2017 | — |
| S-4/A | Filing | Jan 4, 2017 | — |
| S-4 | Registration for a merger or exchange | Dec 2, 2016 | — |
| S-8 | Employee stock plan registration | Aug 15, 2016 | — |
| POS AM | Filing | Nov 23, 2015 | — |
| POS AM | Filing | Nov 23, 2015 | — |
| S-3 | Shelf registration | Jul 10, 2015 | — |
| S-3 | Shelf registration | Jul 10, 2015 | — |
| 424B4 | Prospectus | Feb 19, 2015 | — |
| S-1MEF | Filing | Feb 17, 2015 | — |
| S-1/A | Amended registration statement | Feb 13, 2015 | — |
| FWP | Free writing prospectus | Feb 2, 2015 | — |
| FWP | Free writing prospectus | Feb 2, 2015 | — |
| S-1/A | Amended registration statement | Jan 29, 2015 | — |
| S-1 | Registration statement | Jan 15, 2015 | — |
| S-8 | Employee stock plan registration | Jul 9, 2014 | — |
| 424B4 | Prospectus | Jun 19, 2014 | — |
| S-1/A | Amended registration statement | Jun 13, 2014 | — |
| S-1/A | Amended registration statement | Jun 6, 2014 | — |
| FWP | Free writing prospectus | Jun 2, 2014 | — |
| S-1/A | Amended registration statement | Jun 2, 2014 | — |
| FWP | Free writing prospectus | May 27, 2014 | — |
| S-1/A | Amended registration statement | May 27, 2014 | — |
| S-1/A | Amended registration statement | May 15, 2014 | — |
| S-1/A | Amended registration statement | Apr 9, 2014 | — |
| S-1 | Registration statement | Mar 19, 2014 | — |
Showing 81 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- VRDN (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Waltham, MA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1590750
- Former names
- MIRAGEN THERAPEUTICS, INC. (until Jan 15, 2021); SIGNAL GENETICS, INC. (until Feb 10, 2017); SIGNAL GENETICS LLC (until Jul 9, 2014)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.